Soligenix, Inc. Files 2024 Annual Report
Ticker: SNGX · Form: 10-K · Filed: Mar 21, 2025 · CIK: 812796
| Field | Detail |
|---|---|
| Company | Soligenix, Inc. (SNGX) |
| Form Type | 10-K |
| Filed Date | Mar 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, pharmaceuticals, financials
Related Tickers: SNGX
TL;DR
SOLIGENIX (SNGX) filed its 2024 10-K. Check financials and business ops.
AI Summary
Soligenix, Inc. filed its 10-K for the fiscal year ending December 31, 2024, reporting on its operations and financial condition. The company, formerly known as Dor Biopharma Inc., is based in Princeton, NJ. The filing details its business, including its focus on pharmaceutical preparations, and provides financial information relevant to investors.
Why It Matters
This 10-K filing provides a comprehensive overview of Soligenix, Inc.'s financial health and business strategy for the past fiscal year, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Soligenix faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 1231 — Fiscal Year End (Indicates the end of the reporting period)
Key Players & Entities
- SOLIGENIX, INC. (company) — Filer
- 20241231 (date) — Fiscal Year End
- 20250321 (date) — Filing Date
- Princeton, NJ (location) — Business Address
- DOR BIOPHARMA INC (company) — Former Company Name
- PHARMACEUTICAL PREPARATIONS [2834] (industry) — Standard Industrial Classification
FAQ
What is the primary business of Soligenix, Inc.?
Soligenix, Inc. is primarily involved in the Pharmaceutical Preparations industry, SIC code 2834.
When was this 10-K filing submitted?
This 10-K filing was submitted on March 21, 2025.
What is the fiscal year end for Soligenix, Inc.?
The fiscal year end for Soligenix, Inc. is December 31.
Has Soligenix, Inc. operated under other names?
Yes, Soligenix, Inc. was formerly known as Dor Biopharma Inc., Endorex Corp., and Immunotherapeutics Inc.
Where is Soligenix, Inc. located?
Soligenix, Inc.'s business address is located at 29 Emmons Drive, Suite B-10, Princeton, NJ 08540.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 21, 2025 regarding SOLIGENIX, INC. (SNGX).